Mesoblast Limited - American Depositary Shares — Cash Flow (NASDAQ:MESO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -106.68 M-65.78 M-63.27 M-48.46 M-49.95 M43.83 M — Cash from investing activities -1.65 M-232 K-194 K-97 K120 K1.02 M — Cash from financing activities 114.47 M-9.87 M74.5 M40.25 M147.34 M15.33 M — Free cash flow -106.68 M-65.78 M-63.27 M-48.46 M-49.95 M43.83 M —

News

Flowers Foods Posts Downbeat Q2 Results, Joins OSI Systems, Aveanna Healthcare And Other Big Stocks Movin

MESO Completes Patient Treatment in Chronic Back Pain Study, Stock Up

Mesoblast Targets $10 Billion Market With Regenerative Back Pain Treatment - Mesoblast (NASDAQ:MESO)

H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Movi

Mesoblast Limited (MESO) is a Great Momentum Stock: Should You Buy?

A Fresh Look At Syndax Pharmaceuticals (NASDAQ:SNDX)

Mesoblast: The Commercial Proof Is Now Becoming The Investment Thesis (NASDAQ:MESO)

Mesoblast Limited (MESO) Presents at ASX CEO Connect June 2026 - Slideshow (NASDAQ:MESO) 2026-06-04

Mesoblast Limited: A Risk/Reward Story (NASDAQ:MESO)

Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&D Day Transcript

Why Mesoblast's Move Into DMD Warrants A Speculative Buy (Upgrade) (NASDAQ:MESO)

Mesoblast H1 FY26 slides: first approved MSC product hits $49M